Review Article
CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity
Table 2
Cell cycle modulators and their molecular target optimal therapeutic inhibitors.
| Agent | Target |
| Staurosporine | CDK1, CDK2, CDK4 | Flavopiridol | CDK1, CDK2, CDK4, CCND | Butyrolactone | CDK1, CDK2 | Paullones | CDK1, CDK2, CDK5 | Indirubin | CDK1, CDK2, CDK4, CDK5 | Rapamycin | CCND, CCNA |
Olomoucine | CDK1, CDK2, CDK5 | Isopentenyladenine | CDK1, CDK2 |
|
|